Phase 2 BI 1569912 Indication: Major depressive disorder This compound is under investigation, further information will be available soon. Partnering inquiries Join our team Additional links Central Nervous System Diseases Mental Disorders Bringing Precision to Psychiatry Partnering in Central Nervous System Diseases Partnering in Central Nervous System Diseases
